A Phase II Study of Picoplatin as Second-Line Therapy for Subjects With Resistant or Refractory Small Cell Lung Cancer
Platinum drugs work by binding to DNA and preventing the rapid cell division of tumors.
However, many tumors demonstrate a resistance to platinum drugs. Results from preclinical
studies indicate that picoplatin (previously called AMD473 or ZD0473) may be able to
overcome or partially overcome platinum resistance. More than 500 patients have received
picoplatin in previous Phase I or Phase II clinical trials.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Efficacy and safety (outcomes will be measured approximately 1 year after the last subject has been treated)
Hazel Breitz, MD
Study Director
Poniard Pharmaceuticals
United States: Food and Drug Administration
0402
NCT00116610
June 2005
March 2008
Name | Location |
---|---|
University of Kansas Medical Center | Kansas City, Kansas 66160-7353 |
Southwest Regional Cancer Center | Austin, Texas 78705 |
Georgia Cancer Specialists | Decatur, Georgia 30033 |
Vanderbilt University Medical Center | Nashville, Tennessee 37232-2516 |
Southeastern Medical Oncology Center | Goldsboro, North Carolina 27534 |
Genesis Cancer Center | Hot Springs, Arkansas 71913 |
South Carolina Oncology Associates, PA | Columbia, South Carolina 29210 |
Comprehensive Cancer Center | Glendale, California 91204 |
H. Lee Moffitt Cancer Center | Tampa, Florida 33612 |
Augusta Oncology Associates | Augusta, Georgia 30901 |
Providence Portland Medical Center | Portland, Oregon 97213-3635 |
Oncology Hematology Group of South Florida | Miami, Florida 33176 |
Medical Center of Vincennes | Vincennes, Indiana 47591 |
Hematology Oncology Centers of the Northern Rockies | Billings, Montana 59101 |
Louisiana State University Health Science Center | New Orleans, Louisiana 70112 |
The West Clinic | Memphis, Tennessee 38120 |
Consultants in Medical Oncology & Hematology | Drexel Hill, Pennsylvania 19026 |
Mt. Sinai Medical Center | New York, New York 10029 |
The Center for Cancer Care & Research | St. Louis, Missouri 63141 |
Rush Medical College | Chicago, Illinois 60612 |
Study Site | Los Angeles, California |
Eastern Connecticut Hematology/Oncology | Norwich, Connecticut 06360 |
Central Georgia Hematology Oncology Associates | Macon, Georgia 31201 |
Markey Cancer Center, University of Kentucky | Lexington, Kentucky 40536 |
The Ochsner Clinic | New Orleans, Louisiana 70121-2483 |
University of Missouri / Ellis Fischel Cancer Center | Columbia, Missouri 65203-3299 |
V.A. Sierra Nevada Health Care | Reno, Nevada 89502 |
Dartmouth-Hitchcock Medical Center Hematology/Oncology | Lebanon, New Hampshire 03756 |